The largest community of pharma leaders

Epizyme Strengthens Leadership Team with Appointment of Paolo Tombesi as Chief Financial Officer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced the appointment of Paolo Tombesi as chief financial officer, effective August 2019. Mr. Tombesi brings over 30 years of extensive financial and accounting expertise to Epizyme, most recently serving as the chief financial officer at Insmed, Incorporated. “We are delighted to be bringing Paolo on board. His range of industry and financial….

Recent Articles